Apoptosis as a therapeutic tool in rheumatoid arthritis

Nature Reviews Immunology

Volumn 2, Issue 7, 2002, Pages 527-535

  Pope, Richard M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; TUMOR NECROSIS FACTOR;

APOPTOSIS; FIBROBLAST; INFLAMMATION; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; BIOLOGICAL MODEL; HUMAN; PATHOLOGY;

APOPTOSIS; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL;

EID: 0036636094     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri846     Document Type: Review

References (76)

1. Pope, R. M. & Perlman, H. Current Molecular Medicine: Principles of Molecular Rheumatology (ed. Tsokos, G. C.) 325-361 (Humana Press, Totowa, New Jersey, 2000).
2. Bathon, J. M. et al. Comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N. Engl. J. Med. 343, 1586-1593 (2000).
3. Feldmann, M. Pathogenesis of arthritis: recent research progress. Nature Immunol. 2, 771-773 (2001).
4. Feldmann, M. & Maini, R. N. Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163-196 (2001).
5. Lipsky, P. E. et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N. Engl. J. Med. 343, 1594-1602 (2000).
6. Sugiyama, M. et al. Localization of apoptosis and expression of apoptosis-related proteins in the synovium of patients with rheumatoid arthritis. Ann. Rheum. Dis. 55, 442-449 (1995).
7. Nakajima, T. et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38, 485-491 (1995).
8. Matsumoto, S., Muller-Ladner, U., Gay, R. E., Nishioka, K. & Gay, S. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J. Rheumatol. 23, 1345-1352 (1996).
9. Firestein, G. S. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96, 1631-1638 (1995).
10. Fraser, A., Fearon, U., Reece, R., Emery, P. & Veale, D. J. Matrix metalloproteinase 9, apoptosis and vascular morphology in early arthritis. Arthritis Rheum. 44, 2024-2028 (2001).
11. Firestein, G. S. et al. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 149, 2143-2151 (1996).
12. Perlman, H. et al. Differential expression pattern of the anti-apoptotic proteins, Bcl-2 and Flip in experimental arthritis. Arthritis Rheum. 44, 2899-2908 (2001).
13. Tak, P. P., Zvaifler, N. J., Green, D. R. & Firestein, G. S. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 21, 78-82 (2000).
14. Lawrence. T., Gilroy, D. W., Colville-Nash, P. R. & Willoughby, D. A. Possible new role for NF-κB in the resolution of inflammation. Nature Med. 7, 1291-1297 (2001).
15. Savill, J. Apoptosis in resolution of inflammation. J. Leukocyte Biol. 61, 375-380 (1997).
16. Fadok, V. A., Bratton, D. L. & Henson, P. M. Phagocyte receptors for apoptotic cells: recognition, uptake and consequences. J. Clin. Invest. 108, 957-962 (2001).
17. van Lent, P. L. et al. Uptake of apoptotic leukocytes by synovial lining macrophages inhibits immune-complex-mediated arthritis. J. Leukocyte Biol. 70, 708-714 (2001).
18. Perlman, H. et al. Flice-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J. Exp. Med. 190, 1679-1688 (1999).
19. Perlman, H. et al. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44, 21-30 (2001).
20. Yeh, W.-C. et al. Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12, 633-642 (2000).
21. Hohlbaum, A. M., Gregory, M. S., Ju, S. T. & Marshak-Rothstein, A. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 167, 6217-6224 (2001).
22. Pagliari, L. J., Perlman, H., Liu, H. & Pope, R. M. Macrophages require constitutive NF-κB activation to maintain A1 expression and mitochondrial homeostasis. Mol. Cell. Biol. 20, 8855-8865 (2000).
23. Liu, H. et al. TNF-α gene expression in macrophages: regulation by NF-κB is independent of c-Jun or C/EBPβ. J. Immunol. 164, 4277-4285 (2000).
24. Liu, H., Perlman, H., Pagliari, L. & Pope, R. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages: role of Mcl-1, independent of NF-κB, Bad or caspase activation. J. Exp. Med. 194, 113-125 (2001).
25. Handel, M. L., McMorrow, L. B. & Gravallese, E. M. Nuclear factor-κB in rheumatoid synovium. Arthritis Rheum. 38, 1762-1770 (1995).
26. Davis, R. E., Brown, K. D., Siebenlist, U. & Staudt, L. M. Constitutive nuclear factor-κB activity is required for survival of active B-cell-like diffuse large B-cell lymphoma cells. J. Exp. Med. 194, 1861-1874 (2001).
27. Georganas, C. et al. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-κB but not C/EBPβ or c-Jun. J. Immunol. 165, 7199-7206 (2000).
28. Foxwell, B. et al. Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor-α production in rheumatoid arthritis is NF-κB dependent. Proc. Natl Acad. Sci. USA 95, 8211-8215 (1998).
29. Bondeson, J., Browne, K. A., Brennan, F. M., Foxwell, B. M. J. & Feldmann, M. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J. Immunol. 162, 2939-2945 (1999).
30. Kawakami, A. et al. Inhibition of Fas-antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor-β1. Arthritis Rheum. 39, 1267-1276 (1996).
31. Kobayashi, T. et al. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor-α and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules Arthritis Rheum. 43, 1106-1114 (2000).
32. Franz, J. K. et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 43, 599-607 (2000).
33. Kobayashi, T. et al. Tumor necrosis factor-α regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells. Arthritis Rheum. 42, 519-526 (1999).
34. Zhang, H.-G. et al. Gene therapy that inhibits nuclear translocation of nuclear factor-κB results in tumor necrosis factor-α-induced apoptosis of human synovial fibroblasts. Arthritis Rheum. 43, 1094-1105 (2000).
35. De Smaele, E. et al. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414, 308-313 (2001).
36. Tang, G. et al. Inhibition of JNK activation through NF-κB target genes. Nature 414, 313-317 (2001).
37. Zhang, H. G. et al. Regulation of tumor necrosis factor-α-mediated apoptosis in rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum. 44, 1555-1567 (2001).
38. Pap, T. et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2, 59-64 (2000).
39. Tak, P. P. et al. p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum. 42, 948-953 (1999).
40. Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J. & Green, D. R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl Acad. Sci. USA 94, 10895-10900 (1997).
41. Aupperle, K. R. et al. Regulation of synoviocyte proliferation, apoptosis and invasion by the p53 tumor suppressor gene. Am. J. Pathol. 152, 1091-1098 (1998).
42. Han, Z., Boyle, D. L., Shi, Y., Green, D. R. & Firestein, G. S. Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum. 42, 1088-1092 (1999).
43. Pap, T., Aupperle, K. R., Gay, S., Firestein, G. S. & Gay, R. E. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum. 44, 676-681 (2001).
44. Yamanishi, Y. et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis, Am. J. Pathol. 169, 123-130 (2002).
45. Smolen, J. S. & Steiner, G. Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum. 44, 2218-2220 (2001).
46. Salmon, M. et al. Inhibition of T-cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99, 439-446 (1997).
47. Cantwell, M. J., Hua, T., Zvaifler, N. J. & Kipps, T. J. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 40, 1644-1652 (1997).
48. Kolenko, V. et al. Inhibition of NF-κB activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3 J. Immunol. 163, 590-598 (1999).
49. Moreland, L. W. et al. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum. 38, 1581-1588 (1995).
50. Ito, M. R. et al. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum. 40, 1054-1063 (1997).
51. Hsu, H. C. et al. Defective Fas-ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Arthritis Rheum. 44, 2146-2159 (2001).
52. Zhang, J., Bardos, T., Mikecz, K., Finnegan, A. & Glant, T. T. Impaired Fas signalling pathway is involved in defective T-cell apoptosis in autoimmune murine arthritis. J. Immunol. 166, 4981-4986 (2001).
53. Zhou, T. et al. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T-cell-mediated autoimmune diseases. Nature Med. 5, 42-48 (1999).
54. Harjacek, M. et al. Expression of galectins-1 and -3 correlates with defective mononuclear-cell apoptosis in patients with juvenile idiopathic arthritis. J. Rheumatol. 28, 1914-1922 (2001).
55. Rabinovich, G. A. et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T-cell apoptosis. J. Exp. Med. 190, 385-398 (1999).
56. Zhang, H. et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100, 1951-1957 (1997).
57. Yao, Q. et al. Adenoviral-mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining. J. Gene Med. 2, 210-219 (2000).
58. Sakai, K. et al. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis. Arthritis Rheum. 41, 1251-1257 (1998).
59. Okamoto, K. et al. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther. 5, 331-338 (1998).
60. Tomita, T. et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor-κB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42, 2532-2542 (1999).
61. Tak, P. P. et al. Inhibitor of nuclear factor-κB kinase-β is a key regulator of synovial inflammation. Arthritis Rheum. 44, 1897-1907 (2001).
62. Miagkov, A. V. et al. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl Acad. Sci. USA 95, 13859-13864 (1998).
63. Yao, Q. et al. Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol. Ther. 3, 901-910 (2001).
64. Gerlag, D. M. et al. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 3, 357-361 (2001).
65. Kong, Y. Y., Boyle, W. J. & Penninger, J. M. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol. Today 21, 495-502 (2000).
66. Faouzi, S. et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J. Biol. Chem. 276, 49077-49082 (2001).
67. Fujii, K., Fujii, Y., Hubscher, S. & Tanaka, Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J. Immunol. 167, 1198-1203 (2001).
68. Cutolo, M., Sulli, A., Pizzorni, C., Seriolo, B. & Straub, R. H. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60, 729-735 (2001).
69. Nakazawa, F. et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J. Rheumatol. 28, 1800-1808 (2001).
70. Cutolo, M. et al. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. J. Rheumatol. 27, 2551-2557 (2000).
71. Genestier, L. et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102, 322-328 (1998).
72. Rodenburg, R. J., Ganga, A., van Lent, P. L., van de Putte, L. B. & van Venrooij, W. J. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor-α expression in macrophages by inducing apoptosis. Arthritis Rheum. 43, 1941-1950 (2000).
73. Lugering, A. et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121, 1145-1157 (2001).
74. Frith, J. C., Monkkonen, J., Auriola, S., Monkkonen, H. & Rogers, M. J. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum. 44, 2201-2210 (2001).
75. Barrera, P. et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 43, 1951-1959 (2000).
76. Gratiot-Deans, J., Ding, L., Turka, L. A. & Nunez, G. Bcl-2 proto-oncogene expression during human T-cell development. Evidence for biphasic regulation. J. Immunol. 151, 83-91 (1993).